Katarzyna Petru
Samsung Medison attracted the attention of the medical community during the ISUOG 2025 congress in Cancún, presenting a new generation of ultrasound solutions dedicated to women's health – from the fetal period, through pregnancy and menopause, to care for elderly patients.
HERA Z20 – one device for every stage of a woman's life
The most important premiere was the improved HERA Z20 platform, presented under the slogan "From Challenges to Solutions: Experience the Innovation." This is equipment designed to support doctors in managing patients at every stage – from gynecological issues in teenagers and infertility treatment, to diagnostics during pregnancy and menopause.
Among the new features is PelvicAssist™, which automatically analyzes pelvic structures and calculates the area of the pelvic floor muscle hiatus in 3D. Additionally, Samsung has included three reporting modules compliant with international clinical guidelines: Fibroid 2D (for uterine fibroids according to FIGO), IDEA (for endometriosis), and IETA (for endometrial tumors). All of this is aimed at reducing examination time and making it easier for doctors to describe complicated cases.
An interesting addition is also the Mini ER7 – a probe with a 63% smaller head than traditional ones, designed with the comfort of patients in mind, especially young girls and older individuals.
New Features for High-Risk Pregnancies
The increasing age of mothers means that doctors are more frequently encountering pregnancies with risks. Samsung responds to this trend by adding tests to the system, including the Ophthalmic Artery examination – which allows for early detection of preeclampsia symptoms and monitoring the risk of cardiovascular disorders.
The improved HeartAssist™ feature enables real-time assessment of heart function during pregnancy, while Live ViewAssist™ automatically generates up to 39 ultrasound sections, adding descriptions and measurements in real time. This significantly shortens the diagnostic time and eases the burden on doctors.
Completing the offering is QualityCheck, a tool that automatically evaluates the quality of images during prenatal examinations – ensuring consistency and accuracy of diagnosis.
AI Supports Doctors
– “The new HERA Z20 is not just a hardware update, but a comprehensive solution for women’s health. By combining artificial intelligence with the clinical experience of specialists, we aim to increase diagnostic accuracy and alleviate the burden on doctors, which in the long run can genuinely transform healthcare” – emphasized Jihyun Kim, head of the CX department at Samsung Medison.
In practice, this means that AI-based modules are not a marketing add-on, but real support in daily work. Algorithms analyze ultrasound images in the background, automate measurements, suggest key parameters, and propose guideline-compliant reporting methods. This allows doctors to focus on interpreting results and conversing with the patient rather than wasting time on tedious cross-sectional descriptions or calculations.
In prenatal examinations, where every minute and every millimeter counts, such automation can be crucial. Moreover, consistent report templates compliant with FIGO, IDEA, or IETA align standards – a patient in a large diagnostic center and in a smaller facility receives a description that adheres to the same international guidelines.
AI also has enormous educational potential – less experienced specialists learn faster by observing how the system suggests interpretations of subtle changes that are obvious to an expert. In this sense, the HERA Z20 can be called a “comprehensive solution”: equipment that not only improves image quality but also changes the work model, increases efficiency, and allows for more predictable treatment outcomes.
